Google+ Facebook Twitter Twitter

Vaccine protects against brain damage

Although the pathology of the respiratory system is the main impact of COVID-19, many patients manifest important neurological symptoms, such as anosmia, headaches, malaise, cognitive loss, epilepsy, ataxia and encephalopathy.

Using a mouse model susceptible to the SARS-CoV-2 coronavirus infection, a team of Spanish researchers has demonstrated the ability of SARS-CoV-2 to infect different regions of the brain and to cause brain damage, and how a vaccine developed at the National Biotechnology Centre in Spain fully protects against infection of the brain.

Lead researcher Juan García-Arriaza said: “The results obtained were spectacular, demonstrating that even the administration of a single dose of the MVA-CoV2-S vaccine completely prevents SARS-CoV-2 infection in all brain regions studied and it prevents associated brain damage, even after a reinfection with the virus.”

Image Credit | iStock

Related Articles

COVID-19 immune response over time

Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers at Oregon Health & Science University (OHSU) suggests. The findings carry implications for vaccine recommendations as the pandemic transitions to an endemic state.

One health: seeing the whole ecosystem

With One Health gaining increasing prominence in research and the media, we look at the driving factors behind the concept and ask what action may need to be taken.

Tech news: February 2023

This month's top tech news stories

Insulin: the effect of climate change on medicine

Nigel Crossland argues that we need to revisit manufacturer advice and approaches to insulin, particularly with temperatures increasing.